iBio, Inc. Common Stock
IBIO Real Time Price USDRecent trades of IBIO by members of U.S. Congress
|
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
|---|
|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
Recently reported changes by institutional investors
Quarterly net insider trading by IBIO's directors and management
* Insider trading data parsed from SEC Form 4 filings by Quiver Quantitative. Sign up for the Quiver API for real-time access.
- 1M
- 3M
- 6M
- YTD
- 1Y
- 2Y
- 5Y
- MAX
About
Key Metrics
Return (1d)
Return (30d)
Return (1Y)
CAGR (Total)
Max Drawdown
Beta
Alpha
Sharpe Ratio
Win Rate
Average Win
Average Loss
Annual Volatility
Annual Std Dev
Information Ratio
Treynor Ratio
Total Trades
Metrics Definitions
-
Alpha
Measures a portfolio's risk-adjusted performance against that of its benchmark
Learn More -
Annual Standard Deviation
Measures how much the portfolio's total return varies from its mean or average.
Learn More -
Annual Volatility
A statistical measure of the dispersion of returns for the portfolio.
Learn More -
Average Win
The average return (%) for trades that resulted in a positive return.
-
Average Loss
The average return (%) for trades that resulted in a negative return.
-
Beta
A measure of the volatility of the portfolio compared to the market as a whole.
Learn More -
CAGR
CAGR (Compounded Annual Growth Rate), is the historical annualized rate of return for an investment strategy, throughout the backtest period.
Learn More -
Information Ratio
A measurement of portfolio returns beyond the returns of its benchmark compared to the volatility of those returns.
Learn More -
Max Drawdown
the maximum observed loss from a peak to a trough of a portfolio, before a new peak is attained.
Learn More -
Sharpe Ratio
The Sharpe Ratio is a measure of historical risk-adjusted return, which quantifies the amount of return that an investor received per unit of risk.
Learn More -
Total Trades
The total number of trades made by this strategy.
-
Treynor Ratio
Attempts to measure how successful an investment is in providing compensation to investors for taking on investment risk.
Learn More -
Win Rate
The percentage of total trades that resulted in a positive return.
Be the first to see our newest insights and key updates across all datasets.
Government lobbying spending instances
-
$70,000 Apr 18, 2022 Issue: Health Issues
-
$30,000 Apr 09, 2022 Issue: Budget/Appropriations Medical/Disease Research/Clinical Labs Health Issues
-
$30,000 Jan 16, 2022 Issue: Medical/Disease Research/Clinical Labs Budget/Appropriations Health Issues
-
$70,000 Jan 13, 2022 Issue: HEALTH ISSUES
-
$30,000 Oct 20, 2021 Issue: Health Issues Medical/Disease Research/Clinical Labs Budget/Appropriations
-
$70,000 Oct 19, 2021 Issue: HEALTH ISSUES
-
$20,000 Jul 26, 2021 Issue: Medical/Disease Research/Clinical Labs Budget/Appropriations
-
$10,000 Jul 20, 2021 Issue: Health Issues
-
$30,000 Jul 17, 2021 Issue: Medical/Disease Research/Clinical Labs Budget/Appropriations Health Issues
-
$70,000 Jul 08, 2021 Issue: HEALTH ISSUES
-
$20,000 Apr 20, 2021 Issue: Health Issues
-
$20,000 Apr 19, 2021 Issue: Budget/Appropriations Medical/Disease Research/Clinical Labs
-
$30,000 Apr 19, 2021 Issue: Medical/Disease Research/Clinical Labs Budget/Appropriations Health Issues
-
$70,000 Apr 12, 2021 Issue: HEALTH ISSUES
-
$20,000 Jan 20, 2021 Issue: None
-
$70,000 Jan 18, 2021 Issue: HEALTH ISSUES
-
$10,000 Jan 16, 2021 Issue: Medical/Disease Research/Clinical Labs Health Issues
-
$40,000 Oct 20, 2020 Issue: None
-
$70,000 Oct 16, 2020 Issue: HEALTH ISSUES
-
$40,000 Jul 20, 2020 Issue: None
-
$70,000 Jul 15, 2020 Issue: HEALTH ISSUES
-
$70,000 Apr 17, 2020 Issue: HEALTH ISSUES
-
$70,000 Jan 21, 2020 Issue: HEALTH ISSUES
-
$60,000 Apr 22, 2019 Issue: Health Issues
-
$60,000 Jan 22, 2019 Issue: Health Issues
-
$40,000 Jan 20, 2019 Issue: Health Issues
-
$60,000 Jul 20, 2018 Issue: Health Issues
-
$40,000 Jul 20, 2018 Issue: Health Issues
-
$60,000 Apr 20, 2018 Issue: Health Issues
-
$40,000 Apr 17, 2018 Issue: Health Issues
-
$60,000 Jan 18, 2018 Issue: Health Issues
-
$10,000 Jan 10, 2018 Issue: Health Issues
-
$10,000 Oct 23, 2017 Issue: Health Issues
-
$60,000 Oct 20, 2017 Issue: Health Issues
-
$60,000 Jul 20, 2017 Issue: Health Issues
-
$60,000 Apr 20, 2017 Issue: Health Issues
-
$60,000 Jan 19, 2017 Issue: Health Issues
-
$60,000 Jan 20, 2016 Issue: Health Issues
-
$60,000 Oct 20, 2015 Issue: Health Issues
-
$60,000 Jul 16, 2015 Issue: Health Issues
-
$15,000 Apr 23, 2015 Issue: Health Issues
-
$70,000 Apr 25, 2014 Issue: None
-
$80,000 Jan 27, 2014 Issue: Medical/Disease Research/Clinical Labs
-
$75,000 Oct 16, 2013 Issue: Medical/Disease Research/Clinical Labs
-
$70,000 Jul 25, 2013 Issue: Medical/Disease Research/Clinical Labs
-
$60,000 Jul 24, 2013 Issue: Medical/Disease Research/Clinical Labs
-
$8,000 Jul 19, 2010 Issue: Budget/Appropriations
-
$10,000 Apr 13, 2010 Issue: Budget/Appropriations
-
$15,000 Jan 12, 2010 Issue: Budget/Appropriations
-
$15,000 Oct 20, 2009 Issue: Budget/Appropriations
-
$40,000 Feb 13, 2003 Issue: Health Issues Budget/Appropriations
-
$40,000 Aug 20, 2002 Issue: Health Issues Transportation Budget/Appropriations
Estimated quarterly lobbying spending
IBIO Revenue by Segment or Geography
New patents grants
Federal grants, loans, and purchases
Estimated quarterly amount awarded from public contracts
Recent insights relating to IBIO
Recent picks made for IBIO stock on CNBC
ETFs with the largest estimated holdings in IBIO
- ... Highest Price Target
- ... Median Price Target
- ... Lowest Price Target
|
Analyst
|
Firm
|
Current
|
Previous
|
Date
|
|---|
- Is $IBIO stock a Buy, Sell, or Hold?
- What is the price target for $IBIO stock?
* Analyst consensus is not financial advice. Please see our data disclaimers .
|
Shareholder
|
Shares Held
|
|---|
- Who owns $IBIO stock?
- Who owns the most shares of $IBIO stock?
- What funds own $IBIO stock?
* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view IBIO Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.